KILIÇKAP, S. Et Al. 2018. Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.. IASLC 19th World Conference On Lung Cancer , (Canada), 1020.

KILIÇKAP, S., Öztürk, A., KARADURMUŞ, N., KORKMAZ, T., YUMUK, P. F., ÇİÇİN, İ., ... PAYDAŞ, S.(2018). Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey. . IASLC 19th World Conference On Lung Cancer (pp.1020). , Canada

KILIÇKAP, SAADETTİN Et Al. "Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.," IASLC 19th World Conference On Lung Cancer, Canada, 2018

KILIÇKAP, SAADETTİN Et Al. "Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.." IASLC 19th World Conference On Lung Cancer , Canada, pp.1020, 2018

KILIÇKAP, S. Et Al. (2018) . "Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.." IASLC 19th World Conference On Lung Cancer , Canada, p.1020.

@conferencepaper{conferencepaper, author={SAADETTİN KILIÇKAP Et Al. }, title={Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.}, congress name={IASLC 19th World Conference On Lung Cancer}, city={}, country={Canada}, year={2018}, pages={1020} }